What Is a Quality Agreement Between a Laboratory and Its Pharmaceutical Distributor?

A pharmaceutical distribution relationship brings together commercial, regulatory, and operational decisions. The contract defines the business arrangement; the quality agreement sets out how the parties will work together to protect the product and respond when a deviation occurs.

This document assigns specific responsibilities to the laboratory and the distributor. Its content may vary according to the portfolio, the contracted services, and the applicable regulations, but it typically establishes who approves procedures, retains records, communicates changes, investigates incidents, and coordinates alerts or recalls.

Clarity is essential because contracting a service does not release either party from its responsibilities. The laboratory and distributor must know which tasks they own, what information they must share, and who makes the decision when a problem exceeds day-to-day operations.

A Technical Agreement That Complements the Commercial Relationship

The FDA uses quality agreements to explain how parties can define activities subject to good manufacturing practices in contracted pharmaceutical operations. Although its guidance focuses on manufacturing, the principle is useful for distribution: documenting who does what helps prevent gaps, duplication, and delayed responses.

A commercial agreement may establish prices, territories, goals, or representation terms. By contrast, the quality agreement focuses on the integrity of the medicine and the processes that make it possible to demonstrate that integrity. The two documents should be consistent, but they serve different purposes.

The agreement must also reflect the actual operation. A generic template offers little value if it does not identify products that require special care, services entrusted to third parties, the tools being used, and the people responsible. It should therefore be reviewed whenever the distributed medicines, facilities, regulations, or scope of service change.

Responsibilities That Should Be Put in Writing

Storage and Transportation

The document should specify how the medicine will be stored, how often temperature will be monitored, and who will review the equipment and records. It should also explain what to do if a product leaves the permitted range, how to verify that the packaging and route can protect it, and who decides what happens to units temporarily segregated while the incident is investigated.

The World Health Organization notes that good storage and distribution practices are part of the system that preserves the quality of medical products throughout the supply chain. In Guatemala, the DRCPFA oversees pharmaceutical establishments and maintains procedures for inspection and certification of good practices.

Deviations, Complaints, and Recalls

A deviation occurs when part of the process departs from what was planned—for example, because of a temperature change, damaged packaging, an incomplete document, or an error in order preparation. The agreement should indicate who records the event, who investigates it, and who decides whether the product may be used, must be returned, or requires another measure.

The same precision is needed for complaints, possible defects, and recalls. The laboratory contributes technical knowledge of the product; the distributor can provide lot traceability and customer contact information. A coordinated procedure makes it possible to locate units, stop shipments, and communicate instructions quickly.

Documentation, Audits, and Changes

Records demonstrate how the medicine was received, stored, and delivered. The agreement should therefore establish retention periods, access to information, data protection, and availability during audits. It should also address the review of suppliers or subcontracted services involved in the process.

Finally, each party needs to notify the other of changes that may affect quality: a new warehouse, a route modification, a critical piece of equipment, an information system, or an updated product condition. Agreeing on deadlines and responsible parties prevents a change from reaching operations before the information does.

The Agreement Makes Coordination Verifiable

A strong quality agreement uses specific instructions, identifies the responsible parties, and establishes who to contact when a situation requires a higher-level decision. It also defines monitoring data and periodic reviews. Meetings between the laboratory and distributor can then be based on concrete facts: recorded incidents, response times, audits, complaints, and measures taken to prevent a problem from recurring.

This dynamic strengthens the relationship because it reduces dependence on informal instructions. When a situation requires a rapid response, teams already know the channel, the decision-making authority, and the information they must retain.

The document is not a substitute for evaluating the partner. Licenses, personnel, facilities, procedures, and response capabilities must be verified before operations begin and throughout the relationship. The agreement organizes responsibilities; day-to-day execution demonstrates whether they are being fulfilled.

Agencias J.I. Cohen Provides an Integrated Quality Structure

Agencias J.I. Cohen offers an example of how several capabilities can be brought together around a quality agreement. The company has registered chemistry and pharmacy professionals, quality assurance, regulatory affairs, specialized warehousing, foreign trade, nationwide distribution, and pharmacovigilance.

Its operation applies temperature control, expiration-based inventory management, and verification of good storage and distribution practices. These capabilities make it possible to assign specific owners for product conservation, journey documentation, and communications from the laboratory.

In this way, the agreement stops being an isolated documentation requirement and becomes a working tool. For the laboratory, it provides visibility and monitoring criteria. For the distributor, it establishes clear expectations. For the patient, it helps ensure that every logistics decision serves the same purpose: protecting the medicine’s quality through delivery.